勘误：作者对“鲁斯可皂苷元通过靶向非肌肉型肌球蛋白重链IIA调节TLR4信号通路减轻LPS诱导的肺内皮屏障功能障碍”一文的修正[《中国药理学报B》12 (2022) 1198 - 1212]。
Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212].
作者信息
Wu Yunhao, Yu Xiu, Wang Yuwei, Huang Yalin, Tang Jiahui, Gong Shuaishuai, Jiang Siyu, Xia Yuanli, Li Fang, Yu Boyang, Zhang Yuanyuan, Kou Junping
机构信息
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
出版信息
Acta Pharm Sin B. 2022 Jul;12(7):3198-3199. doi: 10.1016/j.apsb.2022.04.004. Epub 2022 Apr 8.
Abstract
[This corrects the article DOI: 10.1016/j.apsb.2021.09.017.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.apsb.2021.09.017。]
Zotero 插件